Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

Frontiers in Oncology
J Javier HernandezSteven V Molinski

Abstract

The repositioning or "repurposing" of existing therapies for alternative disease indications is an attractive approach that can save significant investments of time and money during drug development. For cancer indications, the primary goal of repurposed therapies is on efficacy, with less restriction on safety due to the immediate need to treat this patient population. This report provides a high-level overview of how drug developers pursuing repurposed assets have previously navigated funding efforts, regulatory affairs, and intellectual property laws to commercialize these "new" medicines in oncology. This article provides insight into funding programs (e.g., government grants and philanthropic organizations) that academic and corporate initiatives can leverage to repurpose drugs for cancer. In addition, we highlight previous examples where secondary uses of existing, Food and Drug Administration- or European Medicines Agency-approved therapies have been predicted in silico and successfully validated in vitro and/or in vivo (i.e., animal models and human clinical trials) for certain oncology indications. Finally, we describe the strategies that the pharmaceutical industry has previously employed to navigate regulatory consid...Continue Reading

References

Mar 27, 2001·Japanese Journal of Cancer Research : Gann·M MiharaD T Wong
May 26, 2004·The Journal of Pharmacology and Experimental Therapeutics·Zeruesenay DestaDavid A Flockhart
Aug 3, 2004·Nature Reviews. Drug Discovery·Ted T Ashburn, Karl B Thor
Aug 10, 2007·Nature·Curtis R Chong, David J Sullivan
Oct 25, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J KimS Noguchi
Dec 2, 2009·Nature Reviews. Drug Discovery·Bernard Munos
Aug 19, 2010·Molecular Cancer Therapeutics·Ming-Ying LanChi-Ying F Huang
Mar 1, 2012·Drug Discovery Today. Therapeutic Strategies·Tudor I OpreaLarry A Sklar
Mar 2, 2012·Nature Reviews. Drug Discovery·Jack W ScannellBrian Warrington
Aug 15, 2012·Drug Discovery Today·Xiaoyan A Qu, Deepak K Rajpal
Sep 18, 2012·Journal of Cancer Science & Therapy·Carlos M Telleria
Oct 2, 2012·American Journal of Respiratory and Critical Care Medicine·Chi-Tai YehChi-Ying F Huang
Jun 25, 2013·Cancer Biology & Therapy·Menghang XiaChristopher P Austin
Aug 24, 2013·Journal of Managed Care Pharmacy : JMCP·Patrick P GleasonNilay D Shah
Jul 12, 2014·IET Systems Biology·Chien-Hung HuangKa-Lok Ng
Jul 31, 2014·Ecancermedicalscience·Pan PantziarkaP Vikas
Oct 22, 2014·Annals of Translational Medicine·Jacek KasznickiJózef Drzewoski
Dec 3, 2014·Urologic Oncology·Fumiya HongoTsuneharu Miki
Apr 3, 2015·Briefings in Bioinformatics·Jiao LiZhiyong Lu
Aug 5, 2015·Assay and Drug Development Technologies·Tudor I Oprea, John P Overington
Sep 24, 2015·Molecular Medicine Reports·Xi-Nan ShiMarie Chia-Mi Lin
Oct 21, 2015·Nature Reviews. Clinical Oncology·Francesco BertoliniGauthier Bouche
Feb 14, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kei SatohElectron Kebebew
May 4, 2016·Journal of Pharmaceutical Policy and Practice·Adam R HoustonAmir Attaran
Jan 22, 2017·British Journal of Clinical Pharmacology·Elin H DaviesDyfrig A Hughes
Feb 16, 2017·BMC Genomics·Bernard Kok Bang LeeSok Ching Cheong
May 24, 2017·Nature Reviews. Clinical Oncology·Pan Pantziarka
Jun 13, 2017·Journal of Oncology Practice·Philip SavageHagop Kantarjian
Aug 7, 2017·Trends in Cancer·Ciska VerbaanderdPan Pantziarka

Citations

Sep 25, 2018·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Keith I BlockCharlotte Gyllenhaal
Sep 28, 2018·Journal of Cellular Biochemistry·Fan JiangChi-Z Zhou
Jan 4, 2019·Chemical Biology & Drug Design·Stephanie S KimSteffen Lindert
Jan 10, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Giulia AlfediAlessandra Rufini
Sep 5, 2019·Archives of Pharmacal Research·Ok-Seon KwonHaeseung Lee
Nov 26, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Jing-Wei LiangFan-Hao Meng
Aug 22, 2019·Medicinal Research Reviews·Catherine H Schein
Feb 20, 2020·Cancers·Anna V WojcickiKathleen M Sakamoto
Jan 11, 2020·Cancer Metastasis Reviews·Hisham F BahmadWassim Abou-Kheir
Sep 17, 2020·Journal of Cellular and Molecular Medicine·Md Abdul Alim Al-Bari
Sep 13, 2020·Biological Reviews of the Cambridge Philosophical Society·Munishwar Nath Gupta, Ipsita Roy
Jul 3, 2018·Frontiers in Pharmacology·Pan PantziarkaNicolas André
Apr 12, 2019·Frontiers in Neuroscience·Ebrahim M YimerKald Beshir Tuem
May 14, 2020·NTM·Mariacarla Gadebusch Bondio, Maria Marloth
Jun 23, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P-T ChiouM G Casarotto
Jul 4, 2020·Signal Transduction and Targeted Therapy·Zhe ZhangCanhua Huang
May 18, 2019·Oxidative Medicine and Cellular Longevity·Emiliano Panieri, Luciano Saso
Feb 12, 2020·Briefings in Bioinformatics·Huimin LuoJianxin Wang
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zachary BarryTimothy W Corson
Dec 24, 2019·Frontiers in Cell and Developmental Biology·Yoo Jin JungNigel H Greig
Apr 19, 2019·Antioxidants·Meenakshi SudhakaranAndrea I Doseff
Mar 6, 2019·Nature Microbiology·Maya A Farha, Eric D Brown
Jul 17, 2020·International Journal of Molecular Sciences·Federica LaudisiCarmine Stolfi
Apr 19, 2018·Frontiers in Microbiology·Andrzej GórskiJan Borysowski
May 16, 2019·Cellular and Molecular Life Sciences : CMLS·Winnie Fong, Kenneth K W To
Oct 24, 2018·Orphanet Journal of Rare Diseases·Kathleen L Miller, Michael Lanthier
Jun 23, 2020·Indian Journal of Pharmacology·Vidya M MahalmaniBikash Medhi
Oct 7, 2020·Molecular Oncology·Jeremy Ariey-BonnetEddy Pasquier
Nov 5, 2020·Briefings in Bioinformatics·Serena DotoloRoberto Tagliaferri
Jun 15, 2019·Current Computer-aided Drug Design·Seyedeh Shaghayegh Sadeghi, Mohammad Reza Keyvanpour
Dec 22, 2020·Briefings in Bioinformatics·Apurva BadkasThomas Sauter
Jul 3, 2019·Molecular Cancer Therapeutics·Joshua CasaosNicolas Skuli
Jan 7, 2021·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Brenda Cabrera-MendozaHumberto Nicolini
Mar 11, 2020·Seminars in Cancer Biology·Vijay P KaleManoj K Pandey

Related Concepts

Malignant Neoplasms
Clinical Trials
Drug Industry
Pharmaceutical Preparations
Philanthropic Funds
Oncologic
Drug Development
Heart Alternation
Pharmacologic Substance
Population Group

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.